| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |